Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- VIVOSCRIPT
- Publication Date
- 2014-06-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] priority statement
[0002] This application claims priority to the following US Provisional Patent Application: US Provisional Patent Application 61 / 509,114, filed July 19, 2011, which is hereby incorporated by reference in its entirety. Background of the invention
[0003] Embryonic stem cells are capable of differentiating into many types of human cells. Most somatic cells are terminally differentiated cells and are thought to lack the ability to transform into other types of somatic cells. Recent advances in the field of induced pluripotent stem cells (iPSCs) and transdifferentiation have changed this paradigm. Ectopic expression of four transcription factors, Oct4 (e.g., SEQ ID NO:1), Sox2 (e.g., SEQ ID NO:2), Klf4 (e.g., SEQ ID NO:3), and cMyc (e.g., SEQ ID NO:4) by viral transduction , somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) (Okita et al., Nature 448, 313-317 (2007); Takahashi and Yamanaka, Cell 126, 663-676 (2006)). A num...